Interweaving Microglial Senescence And Gut Microbiome Dynamics In Alzheimer’S Disease - Mechanisms And Therapeutic Frontiers
Alzheimer’s disease, a condition marked by memory loss and declining brain function, is increasingly understood to be influenced by more than just the well-known amyloid and tau protein issues. Scientists are now focusing on the role of ongoing brain inflammation and a disrupted immune system throughout the body. It appears that two key players in this process are the aging of specialized brain immune cells, called microglia, and an imbalance in the gut’s bacterial community.
When microglia age, they become less effective at clearing harmful substances and instead start releasing inflammatory signals, which can further damage brain cells. Simultaneously, an unhealthy balance of gut bacteria, known as dysbiosis, can lead to increased inflammation throughout the body and weaken the protective barriers in both the gut and the brain. Substances produced by these gut bacteria can travel to the brain and directly affect microglia, accelerating their aging and worsening the disease.
Understanding these connections opens up new avenues for treatment. Strategies could involve revitalizing these aging brain immune cells or restoring a healthy balance to the gut microbiome through approaches like probiotics, prebiotics, dietary changes, or even fecal microbiota transplantation. Future treatments may also involve personalized medicine, tailoring interventions based on an individual’s unique gut bacteria profile and genetic makeup.
Source: link to paper